Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Divi’s Laboratories begins commercial production at Visakhapatnam unit
The unit of the company is located at Chippada village, Bheemunipatnam Mandal
Drug firm Divi's Laboratories said it has begun…
US FDA accepts Mylan and Biocon’s proposed biosimilar bevacizumab for review
The FDA goal date set under the Biosimilar User Fee Act (BsUFA) is December 27, 2020
Biocon and Mylan announced that the US…
Women Leaders: Changing the Dynamics of Corporate
Chandra Ganjoo, Group CPO & Executive Director, Trivitron Healthcare writes about the need for more women to be in leadership…
Without innovation in Ayurveda, we can’t get global recognition: Piyush Goyal
Dr GG Gangadharan, President, CISSA & Secretary General, Global Ayurveda Festival 2020 asserted that GAF 2020 will galvanize…
Indian pharma industry likely to reach $100-bn and medical devices sector reach $50-bn by 2025 : D V…
He spoke at the India Pharma and India Medical Device 2020 event where FICCI-EY report ‘Reshaping India into a life sciences…
Three Indian universities among the top 200 for pharma education: QS World University Rankings
For the Chemical Engineering category, 14 Indian universities made it to the top 400 ranks, with IIT Bombay ranking among the top…
VAV to hold a seminar on drug delivery systems in Mumbai
The event will also offer participating students an opportunity to present their phospholipids based research papers followed by a…
No shortage of drug ingredients for next three months; daily monitoring of coronavirus situation:…
All initiatives are being taken to ensure there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V…
Zydus announces world’s first drug for the treatment of Non-Cirrhotic NASH
Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic…
HC stays order asking J&J to deposit over Rs 230 cr ‘profiteered’ from sale of baby…
The court issued notice to the Centre, NAPA and Director General of Anti-Profiteering seeking their stand on the company's…